• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质水平对三阴性乳腺癌患者肿瘤浸润淋巴细胞及预后的影响

Effect of Lipid Levels on Tumor-Infiltrating Lymphocytes and Prognosis in Patients with Triple-Negative Breast Cancer.

作者信息

AiErken NiJiati, Shao Nan, Liu Yuhong, Shi Huijuan, Shi Yawei, Yuan Zhongyu, Lin Ying

机构信息

Department of Breast and Thyroid Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.

Breast Disease Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

出版信息

Breast Care (Basel). 2023 Oct;18(5):390-398. doi: 10.1159/000531943. Epub 2023 Aug 29.

DOI:10.1159/000531943
PMID:37901045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10601676/
Abstract

OBJECTIVE

Dyslipidemia can promote cell proliferation, malignant transformation, metastasis, and cancer recurrence. Moreover, it could also affect immune infiltration in the tumor microenvironment. Therefore, we aimed to explore the effects of lipid levels on tumor-infiltrating lymphocytes (TILs) and prognosis in patients with triple-negative breast cancer (TNBC).

METHODS

Samples from 222 patients with TNBC from July 2007 to December 2019 were obtained from the tissue specimen banks in 3 hospitals. The blood samples were used to detect the levels of lipid levels such as apolipoprotein B (Apo B), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C). The TILs in the 222 TNBC tissues were detected using hematoxylin and eosin (H&E) staining, and the relationship between the lipid levels, clinical characteristics, and prognosis was analyzed.

RESULTS

Among TNBC patients, the overall survival (OS) time and disease-free survival (DFS) time were lower in patients with high LDL-C levels than those with low LDL-C levels ( < 0.01, respectively). The DFS was shorter in patients with low stromal TIL (STIL) levels than those with moderate or high STIL levels ( 0.023). Multifactor Cox regression analysis showed that LDL-C level, Apo B level, and lymphocyte-predominant breast cancer were independent risk factors for OS in TNBC patients. The number of positive lymph nodes, postoperative staging, and total amount of TILs were independent risk factors for DFS in TNBC patients.

CONCLUSION

The LDL-C and STIL levels were correlated with survival and prognosis in patients with TNBC.

摘要

目的

血脂异常可促进细胞增殖、恶性转化、转移及癌症复发。此外,它还可能影响肿瘤微环境中的免疫浸润。因此,我们旨在探讨血脂水平对三阴性乳腺癌(TNBC)患者肿瘤浸润淋巴细胞(TILs)及预后的影响。

方法

从3家医院的组织标本库中获取2007年7月至2019年12月期间222例TNBC患者的样本。采集血样检测载脂蛋白B(Apo B)、甘油三酯(TG)和低密度脂蛋白胆固醇(LDL-C)等血脂水平。采用苏木精-伊红(H&E)染色检测222例TNBC组织中的TILs,并分析血脂水平、临床特征与预后之间的关系。

结果

在TNBC患者中,高LDL-C水平患者的总生存期(OS)和无病生存期(DFS)均低于低LDL-C水平患者(分别为<0.01)。基质TIL(STIL)水平低的患者DFS短于STIL水平中等或高者(P=0.023)。多因素Cox回归分析显示,LDL-C水平、Apo B水平和淋巴细胞为主型乳腺癌是TNBC患者OS的独立危险因素。阳性淋巴结数量、术后分期和TILs总量是TNBC患者DFS的独立危险因素。

结论

LDL-C和STIL水平与TNBC患者的生存及预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/10601676/d5a1d097c513/brc-2023-0018-0005-531943_F04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/10601676/fc217adcf3a4/brc-2023-0018-0005-531943_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/10601676/b5567c247731/brc-2023-0018-0005-531943_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/10601676/54939603a754/brc-2023-0018-0005-531943_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/10601676/d5a1d097c513/brc-2023-0018-0005-531943_F04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/10601676/fc217adcf3a4/brc-2023-0018-0005-531943_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/10601676/b5567c247731/brc-2023-0018-0005-531943_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/10601676/54939603a754/brc-2023-0018-0005-531943_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/10601676/d5a1d097c513/brc-2023-0018-0005-531943_F04.jpg

相似文献

1
Effect of Lipid Levels on Tumor-Infiltrating Lymphocytes and Prognosis in Patients with Triple-Negative Breast Cancer.脂质水平对三阴性乳腺癌患者肿瘤浸润淋巴细胞及预后的影响
Breast Care (Basel). 2023 Oct;18(5):390-398. doi: 10.1159/000531943. Epub 2023 Aug 29.
2
Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.三阴性乳腺癌患者肿瘤浸润淋巴细胞的预后价值:系统评价和荟萃分析。
BMC Cancer. 2020 Mar 4;20(1):179. doi: 10.1186/s12885-020-6668-z.
3
Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.肿瘤浸润淋巴细胞弥漫分布是三阴性乳腺癌预后较好和化疗效果较好的标志物。
Breast Cancer Res Treat. 2019 Nov;178(2):283-294. doi: 10.1007/s10549-019-05390-x. Epub 2019 Aug 12.
4
Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy.新辅助化疗后三阴性乳腺癌患者肿瘤浸润淋巴细胞亚群在残留肿瘤中的预后价值。
Chin Med J (Engl). 2020 Mar 5;133(5):552-560. doi: 10.1097/CM9.0000000000000656.
5
Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers.肿瘤浸润淋巴细胞与三阴性乳腺癌而非雌激素受体阳性乳腺癌的更好的总生存期和无病生存期显著相关。
Hum Pathol. 2017 Jun;64:7-12. doi: 10.1016/j.humpath.2017.01.004. Epub 2017 Jan 30.
6
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.一种免疫分层揭示了PD-1/LAG-3双阳性三阴性乳腺癌的一个亚群。
Breast Cancer Res. 2016 Dec 3;18(1):121. doi: 10.1186/s13058-016-0783-4.
7
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.肿瘤浸润淋巴细胞(TILs)是国际乳腺癌研究组(IBCSG)III期随机临床试验22-00中三阴性乳腺癌患者的一个有力预后标志物。
Breast Cancer Res Treat. 2016 Jul;158(2):323-31. doi: 10.1007/s10549-016-3863-3. Epub 2016 Jul 2.
8
Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC).肿瘤浸润淋巴细胞(TILs)可改善三阴性乳腺癌(TNBC)患者的预后。
Oncoimmunology. 2015 Jul 27;4(9):e985930. doi: 10.4161/2162402X.2014.985930. eCollection 2015 Sep.
9
The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).免疫检查点抑制剂的治疗候选物由三阴性乳腺癌(TNBC)中肿瘤浸润淋巴细胞(TILs)和程序性死亡配体 1(PD-L1)表达的状态所阐明。
Breast Cancer. 2018 Jan;25(1):34-42. doi: 10.1007/s12282-017-0781-0. Epub 2017 May 9.
10
Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer.三阴性乳腺癌患者肿瘤浸润淋巴细胞分析的临床有效性。
Ann Oncol. 2016 Feb;27(2):249-56. doi: 10.1093/annonc/mdv571. Epub 2015 Nov 23.

引用本文的文献

1
Impact of serum lipids on prognosis in breast cancer patients: a systematic review and meta-analysis.血清脂质对乳腺癌患者预后的影响:一项系统评价和荟萃分析。
World J Surg Oncol. 2025 Jun 13;23(1):234. doi: 10.1186/s12957-025-03875-2.

本文引用的文献

1
Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities.癌症中的胆固醇代谢:机制与治疗机遇。
Nat Metab. 2020 Feb;2(2):132-141. doi: 10.1038/s42255-020-0174-0. Epub 2020 Feb 10.
2
Cholesterol Induces CD8 T Cell Exhaustion in the Tumor Microenvironment.胆固醇在肿瘤微环境中诱导 CD8 T 细胞耗竭。
Cell Metab. 2019 Jul 2;30(1):143-156.e5. doi: 10.1016/j.cmet.2019.04.002. Epub 2019 Apr 25.
3
Updating the role of obesity and cholesterol in breast cancer.更新肥胖和胆固醇在乳腺癌中的作用。
Breast Cancer Res. 2019 Mar 1;21(1):35. doi: 10.1186/s13058-019-1124-1.
4
Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes.绝经后妇女乳腺癌亚型中诊断前甘油三酯和高密度脂蛋白胆固醇对乳腺癌复发和生存的影响。
BMC Cancer. 2018 Jun 15;18(1):654. doi: 10.1186/s12885-018-4568-2.
5
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells.胆固醇代谢物27-羟基胆固醇通过作用于免疫细胞促进乳腺癌转移。
Nat Commun. 2017 Oct 11;8(1):864. doi: 10.1038/s41467-017-00910-z.
6
Plasma apolipoprotein A1 levels at diagnosis are independent prognostic factors in invasive ductal breast cancer.诊断时的血浆载脂蛋白A1水平是浸润性导管癌的独立预后因素。
Discov Med. 2017 Apr;23(127):247-258.
7
An empirically derived dietary pattern associated with breast cancer risk is validated in a nested case-control cohort from a randomized primary prevention trial.一种与乳腺癌风险相关的经验性饮食模式在一项随机初级预防试验的巢式病例对照队列中得到验证。
Clin Nutr ESPEN. 2017 Feb;17:8-17. doi: 10.1016/j.clnesp.2016.10.008. Epub 2016 Nov 23.
8
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.乳腺癌肿瘤浸润淋巴细胞的标准化评估:国际免疫肿瘤生物标志物工作组环研究的结果。
Mod Pathol. 2016 Oct;29(10):1155-64. doi: 10.1038/modpathol.2016.109. Epub 2016 Jul 1.
9
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer.肿瘤浸润淋巴细胞:新辅助治疗 HER2 阳性乳腺癌的预测和预后生物标志物。
Clin Cancer Res. 2016 Dec 1;22(23):5747-5754. doi: 10.1158/1078-0432.CCR-15-2338. Epub 2016 May 17.
10
The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis.肿瘤浸润淋巴细胞在乳腺癌中的预后价值:一项系统评价与Meta分析
PLoS One. 2016 Apr 13;11(4):e0152500. doi: 10.1371/journal.pone.0152500. eCollection 2016.